Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L11 pseudogene 2 (RPL11P2) is a processed pseudogene in the human genome related to the functional ribosomal protein L11 gene (RPL11), which encodes a component of the 60S ribosomal subunit involved in cellular protein synthesis. RPL11P2 does not produce a functional protein, has no established biological role, and is not associated with disease pathogenesis or therapeutic targeting. Pseudogenes such as RPL11P2 are primarily considered relics of evolution without current biological function, although their transcripts may occasionally have regulatory functions in rare cases, which is not documented here. If you are seeking druggable targets related to ribosomal function, the appropriate entry would be the protein-coding gene RPL11 (Ribosomal protein L11), not its pseudogene.
Not applicable; pseudogene does not have protein product or known biological activity relevant to drug action
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L11 pseudogene 2 (RPL11P2).